Apriem Advisors’s Aegerion Pharmaceuticals AEGR Stock Holding History

Apriem Advisors’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,000	Closed	-$3K	–	766
2016 Q3	$3K	Hold	1,000	–	–	﹤0.01%	530
2016 Q2	$1K	Hold	1,000	–	–	﹤0.01%	572
2016 Q1	$4K	Hold	1,000	–	–	﹤0.01%	483
2015 Q4	$10K	Buy	+1,000	New	+$12K	﹤0.01%	378

Apriem Advisors's AEGR Position: Q4 2016 in Review

Apriem Advisors sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 1,000 shares — an estimated $3K sold.

Apriem Advisors first reported a position in AEGR in Q4 2015 and held it in 4 quarters. The position peaked at $10K in Q4 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Apriem Advisors reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Apriem Advisors sold 1,000 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $3K.
Apriem Advisors first reported a position in Aegerion Pharmaceuticals in Q4 2015 and held it in 4 quarters.
Apriem Advisors's Aegerion Pharmaceuticals position peaked at $10K in Q4 2015.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Apriem Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.